Successful Use of Tofacitinib in Scleroderma Arthropathy.

Mediterr J Rheumatol

Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, Odisha, India.

Published: June 2023

Musculoskeletal manifestations of systemic sclerosis (SSc) are frequent and may be one of the early manifestations of the disease. However, arthralgia, pain and stiffness without frank arthritis usually constitute the clinical picture, while overlap syndromes such as rheumatoid-like polyarthritis can dominate when the arthritis is erosive. Hereby, we report a case of primary SSc presenting as frank erosive arthritis involving small and large joints mimicking rheumatoid arthritis, unresponsive to methotrexate, which was successfully treated with tofacitinib.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466352PMC
http://dx.doi.org/10.31138/mjr.34.2.266DOI Listing

Publication Analysis

Top Keywords

successful tofacitinib
4
tofacitinib scleroderma
4
scleroderma arthropathy
4
arthropathy musculoskeletal
4
musculoskeletal manifestations
4
manifestations systemic
4
systemic sclerosis
4
sclerosis ssc
4
ssc frequent
4
frequent early
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!